Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 91

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Beyond the Biological Baseline: Dr. Grace Blest-Hopley on Developing Female-Inclusive Psychedelic Frameworks

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic Consciousness

Rachel Turetzky, PhD & Douglas S. Wingate, DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy

COMPASS Pathways to participate in upcoming September investor conferences

PT436 – The Power of Sound: The Magic in Live Performances,...

Cybin Set to Acquire British DMT Drug Developer Small Pharma

PT435 – The Federal Right to Try Act, The Farm Bill,...

Sunstone Therapies in Collaboration with the University of Vermont Announces Publication...

GH Research Reports Second Quarter 2023 Financial Results and Provides Business...

PT434 – Kiyumí Retreats, Building Somatic Literacy, and Navigating Group Facilitation...

Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development

Psyence Group Announces Closing of Private Placement & Conclusion of Loan...

Psychedelic Retreats: The Ultimate Working Vacation

Load more

EDITOR PICKS

Beyond the Biological Baseline: Dr. Grace Blest-Hopley on Developing Female-Inclusive Psychedelic...

Q1 2026: Oregon Psilocybin Services Update

Psychedelic Funding Update: Q2 2026

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©